Surveillance of Medication Use During Pregnancy in the Mini-Sentinel Program

    Basic Details
    Date
    Tuesday, December 8, 2015
    Type
    Publication
    Medical Product
    angiotensin-converting enzyme (ACE) inhibitor
    anticonvulsant
    dabigatran
    lisinopril
    methotrexate
    mycophenolate mofetil
    paroxetine
    ribavirin
    selective serotonin reuptake inhibitor (SSRI)
    simvastatin
    sodium valproate
    statin
    valproic acid
    warfarin
    Description

    This article describes the capability of the Mini-Sentinel pilot to provide prevalence rates of medication use among pregnant women delivering a liveborn infant.

    The cohorts of interest are women ages 10 to 54 delivering a liveborn infant, and age- and date-matched non-pregnant women.

    Information
    Time Period
    2001-2012
    Data Source(s)
    Mini-Sentinel Distributed Database (MSDD)
    Author(s)

    Susan Andrade ScD; Darren Toh ScD; Monika Houstoun PharmD, MPH; Katrina Mott MHS; Marilyn Pitts PharmD; Caren Kieswetter MD, MPH; Carrie Ceresa PharmD, MPH; Katie Haffenreffer BS; Marsha Reichman PhD

    Corresponding Author

    S. Andrade, Meyers Primary Care Institute (Fallon Community Health Plan, Reliant Medical Group, and University of Massachusetts Medical School), 630 Plantation St., Worcester, MA, 01605, USA. Email: sandrade@meyersprimary.org